-
Machine Learning-Guided LNP Design for Microglial mRNA Deliv
2026-05-06
This study pioneers a machine learning-assisted approach to engineer lipid nanoparticles (LNPs) for targeted mRNA delivery that reprograms hyperactivated microglia. By screening 216 LNP variants and deploying supervised neural networks, the team identifies optimized, hyaluronic acid-modified LNPs that modulate inflammatory microglial responses, advancing neuroinflammatory disorder therapeutics.
-
RNA Pol II Inhibition Triggers Apoptosis Independent of Tran
2026-05-05
Harper et al. (2025) reveal that cell death following RNA polymerase II (Pol II) inhibition arises from active apoptotic signaling triggered by the loss of hypophosphorylated Pol IIA, not from passive mRNA decay. These findings redefine mechanistic assumptions about cell death in response to transcriptional inhibition and have implications for cancer therapy development.
-
Machine Learning-Guided LNPs for mRNA Repolarization of Micr
2026-05-05
Rafiei et al. (2025) present a machine learning-driven framework for designing immunomodulatory lipid nanoparticles to deliver mRNA into hyperactivated microglia, aiming to modulate neuroinflammatory responses. Their integrative approach advances the field of targeted mRNA delivery and highlights the potential of predictive modeling to accelerate development of RNA-based neurotherapeutics.
-
Entamoeba histolytica Peroxiredoxin Triggers Macrophage Auto
2026-05-04
This study demonstrates that peroxiredoxin (Prx) from Entamoeba histolytica activates autophagy in host macrophages via the TLR4–TRIF pathway, contributing to cytotoxicity through autophagy-dependent cell death. These findings reveal a novel mechanism of host-pathogen interaction, with implications for understanding parasite immune evasion and potential therapeutic targeting.
-
Polyethylenimine Linear (PEI MW 40,000) for High-Efficiency
2026-05-04
Polyethylenimine Linear (PEI), MW 40,000, empowers researchers to achieve robust, scalable transfection from 96-well plates to bioreactors. Its unique balance of efficiency, serum compatibility, and reproducibility sets new standards for transient gene expression and recombinant protein production across diverse cell lines.
-
Indomethacin in Inflammation and Lipid Metabolism Research
2026-05-03
Indomethacin’s unique mechanism—combining Cox-1 inhibition, PPARγ agonism, and membrane modulation—makes it indispensable for advanced inflammation and lipid metabolism studies. This article delivers actionable guidance on deploying APExBIO’s Indomethacin for cell-based and in vivo assays, with troubleshooting tips and protocol enhancements anchored in the latest SEMA3E-beige adipocyte research.
-
HATU: Precision Coupling in Peptide Synthesis Chemistry
2026-05-02
HATU is a highly efficient peptide coupling reagent enabling rapid, high-yield amide bond formation. It functions via OAt-active ester intermediates and outperforms older coupling agents in minimizing epimerization. APExBIO’s HATU (SKU A7022) is widely adopted in both academic and pharmaceutical research.
-
Generation of Functional Hepatobiliary Organoids from hiPSCs
2026-05-01
This study establishes a robust protocol for generating functional hepatobiliary organoids from human induced pluripotent stem cells (hiPSCs) without exogenous cells or genetic modification. The resulting organoids recapitulate key aspects of human liver development, offering a reproducible platform for disease modeling and drug discovery.
-
Cy5 TSA Fluorescence System Kit: Precision Signal Amplificat
2026-05-01
The Cy5 TSA Fluorescence System Kit harnesses horseradish peroxidase catalyzed tyramide deposition for game-changing sensitivity in immunohistochemistry and in situ hybridization. This kit empowers researchers to confidently detect low-abundance targets, streamline workflows, and overcome bottlenecks in advanced cellular and molecular imaging.
-
Deuterated Tetrazole CYP51 Inhibitor: Advancing Antifungal T
2026-04-30
This study reports the development of a deuterated tetrazole CYP51 inhibitor (V23) with broad-spectrum antifungal activity and improved selectivity against human CYPs. The findings demonstrate significant in vitro and in vivo efficacy, offering a new direction for overcoming drug-resistant fungal infections and addressing unmet clinical needs.
-
Caspase-8 Activation by Hyperthermia and Cisplatin: Mechanis
2026-04-30
This study demonstrates that combining hyperthermia with cisplatin triggers enhanced caspase-8 accumulation and activation, leading to increased apoptosis and pyroptosis in cancer cells. The findings reveal a novel mechanistic link between K63-linked polyubiquitination of caspase-8 and programmed cell death, with implications for optimizing combination cancer therapies.
-
YAP-TEAD Links PPARα Activation to Liver Regeneration in Mic
2026-04-29
This study elucidates the YAP-TEAD pathway as a central mediator of PPARα-driven hepatomegaly and liver regeneration in murine models. The findings clarify mechanistic underpinnings relevant to metabolic disorder research and offer a robust framework for using selective PPARα agonists in hepatic regeneration studies.
-
Dual-Genome OXPHOS Disruption: LRPPRC Inhibition & Dasatinib
2026-04-29
This study identifies a synergistic anti-tumor effect through the combination of LRPPRC inhibition and dasatinib, targeting both mitochondrial and nuclear-encoded OXPHOS genes. The research provides a mechanistic rationale for dual-genome OXPHOS disruption as a refined strategy for tumor-selective metabolic targeting.
-
Angiotensin II in Vascular Remodeling and Hypertension Model
2026-04-28
Harnessing the power of Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe), researchers can model hypertension and vascular injury with high fidelity. This article delivers actionable workflows, troubleshooting insights, and translational guidance, integrating recent breakthroughs and APExBIO’s rigorously validated reagent.
-
Structural Insights into the Nipah Virus Polymerase Complex
2026-04-28
This study presents high-resolution structures of the Nipah virus L-P polymerase complex, revealing the organization and interactions critical for viral RNA synthesis. These findings offer a molecular framework for designing antiviral strategies targeting the polymerase machinery in emerging zoonotic viruses.